Companies Dominating the Cancer Drugs Landscape
- F. Hoffman-La Roche Ltd
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Celgene Corp
- Novartis AG
- Pfizer Inc
- Johnson and Johnson
- AstraZeneca PLC
- Astellas Pharma Inc
- Merck & Co.
- Bristol Myers Squibb Company
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of cancer drugs is estimated at USD 205.16 billion.
Cancer Drugs Market size was valued at USD 187.33 billion in 2024 and is likely to cross USD 744.68 billion by 2037, expanding at more than 11.2% CAGR during the forecast period i.e., between 2025-2037.
Asia Pacific industry is estimated to dominate majority revenue share by 2037, owing to increasing awareness, rise in disposable incomes, high incidence rate of cancer, and need to develop innovative cancer treatment solutions in the region.
The major players in the market are F. Hoffman-La Roche Ltd, Celgene Corp, Novartis AG, Pfizer Inc, Johnson and Johnson, among others.
